Cytoreductive Surgery
18
2
3
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 18 trials
100.0%
+13.5% vs benchmark
11%
2 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (18)
Impact of an Omega-3 Enriched Oral Nutritional Supplement on Improving Surgical Outcomes in Patients With Peritoneal Carcinomatosis Undergoing Cytoreductive Surgery
Ventral Hernias Following Cytoreductive Surgery : Incidence, Risk Factors and Surgical Management.
Esketamine for Prevention of Depression After Cytoreductive Surgery in Ovarian Cancer
CRS & HIPEC for Platinum-Resistant Recurrent Ovarian Cancer (KOV-02R, RECOVER)
HIPEC Surgery and Hemodynamics
Effect of Urine-guided Hydration on Acute Kidney Injury After CRS-HIPEC
Quadratus Lumborum Block After Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy
Changes in Coagulation in Colorectal Cancer Patients Undergoing Surgical Treatment
Anesthesia Management in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
PET/MRI in Endometrial Cancer
ECO-LEAK Technique: Early Detection of Colorectal Anastomotic Leakage by Transvaginal Ultrasound
Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancer
TAP and IMS for HIPEC
Single Dose Tranexamic Acid in Reducing Blood Loss During Cytoreductive Surgery and HIPEC
Preoperative Systemic Therapy for Colorectal Cancer Peritoneal Metastases
Role of Magnetic Resonance Enterography for Predicting Peritoneal Cancer Index
What Are the Experiences of Patients With Pseudomyxoma Peritonei?
Does Serum Procalcitonin Levels Predict Sepsis in Patients Undergoing Cytoreductive Surgery